Clinical trial
Cellular Immune Augmentation in Colon and Rectal Cancer
NCT00257322 · University of California, Irvine, Other · Completed
Key facts
| NCT number | NCT00257322 |
|---|---|
| Title | Cellular Immune Augmentation in Colon and Rectal Cancer |
| Official title | A Pilot Study of Cellular Immune Augmentation in Colon and Rectal Cancer Therapy |
| Lead sponsor | University of California, Irvine, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colon Cancer, Rectal Cancer |
| Intervention type | Drug |
| Interventions | GM-CSF |
| Enrollment | 20 |
| Start date | Apr 1, 2003 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Nov 22, 2005 |
| Last update posted | Oct 31, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: